Conjugated Estrogen

DRUG4 trials

Sponsors

Loyola University, Universidade Federal do Paraná, University of Pennsylvania, Mayo Clinic

Conditions

Endometrial HyperplasiaIschemia Reperfusion InjuryOveractive BladderPelvic Organ ProlapseUrinary Tract InfectionsVaginitis Atropic

Phase 1

Intravenous Estrogen in Kidney Transplant Study

Active, not recruitingNCT03663543

University of PennsylvaniaIschemia Reperfusion Injury

Start: 2016-08-26End: 2026-05-01Target: 30Updated: 2025-04-02

Phase 4

Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients

CompletedNCT03032848

Universidade Federal do ParanáEndometrial Hyperplasia, Pelvic Organ Prolapse, Vaginitis Atropic

Start: 2013-11-26End: 2016-12-26Updated: 2019-05-01

Unknown Phase

The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides

CompletedNCT02524769

Loyola UniversityOveractive Bladder

Start: 2015-12-31End: 2017-06-30Updated: 2021-04-15

Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection

CompletedNCT04301934

Mayo ClinicUrinary Tract Infections

Start: 2020-06-01End: 2023-04-30Updated: 2024-03-26

Related Papers

Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms.

2020-08-1160 citations

LBA01-12 IMPROVEMENT IN OAB SYMPTOMS AFTER VAGINAL ESTROGEN THERAPY IS ASSOCIATED WITH MEASURABLE PELVIC MICROBIOME CHANGES

The Journal of Urology2020-04-01